ID: ALA13069

Max Phase: Preclinical

Molecular Formula: C12H15NO2

Molecular Weight: 205.26

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COc1cccc2c1C=[N+]([O-])C(C)(C)C2

Standard InChI:  InChI=1S/C12H15NO2/c1-12(2)7-9-5-4-6-11(15-3)10(9)8-13(12)14/h4-6,8H,7H2,1-3H3

Standard InChI Key:  ZGQILBAMXJZVMH-UHFFFAOYSA-N

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 205.26Molecular Weight (Monoisotopic): 205.1103AlogP: 1.96#Rotatable Bonds: 1
Polar Surface Area: 35.30Molecular Species: ACIDHBA: 2HBD: 0
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: 1.11CX Basic pKa: CX LogP: -0.92CX LogD: 1.11
Aromatic Rings: 1Heavy Atoms: 15QED Weighted: 0.52Np Likeness Score: 0.58

References

1. Bernotas RC, Thomas CE, Carr AA, Nieduzak TR, Adams G, Ohlweiler DF, Hay DA.  (1996)  Synthesis and radical scavenging activity of 3,3-dialkyl-3,4-dihydro-isoquinoline 2-oxides,  (10): [10.1016/0960-894X(96)00181-3]

Source